Paone D, Des Jarlais D C, Caloir S, Clark J, Jose B
Chemical Dependency Institute, Beth Israel Medical Center, N.Y., NY 10003, USA.
J Community Health. 1995 Apr;20(2):111-23. doi: 10.1007/BF02260333.
It is estimated that 50% of the approximate 200,000 intravenous drug users (IDUs) in New York City (NYC) are infected with HIV. Syringe exchange, a common method of HIV prevention in many countries was legalized in NYC in 1992. As syringe exchange has gained public support and the number of functioning exchangers has grown in the country, more attention has been given to the study of operational characteristics of syringe exchanges. Syringe exchanges may be considered health service delivery organizations, and the specific methods of service delivery may greatly influence their effectiveness in reducing HIV risk behavior among injecting drug users. Improving operational characteristics of syringe exchanges requires both careful data collection, in order to reduce ambiguity in interpretation, and methods for cumulating knowledge, so that previous learning experiences need not be repeated with each new exchange. We report here on the practice of marking ("tagging") syringes distributed by exchanges in NYC during the period from 1990 through 1994. During this period the NYC exchanges operated illegally as underground exchanges, and then received legal status and expanded greatly. Developing regulations that reflect the reality of the program operations while allowing for monitoring and oversight is a complicated process, especially when implemented in states that maintain paraphernalia and prescription laws and where "unauthorized" possession of injection equipment remains a criminal activity under existing legal statutes. The particular situation in NYC which required the revision of existing regulations during a period of rapid program expansion and implementation of a large system of syringe exchange further illustrates the multiple pressures which accompany such a process. In order to implement meaningful regulations which maximize the public health benefits of syringe exchange programs on an individual and community level, recommendations are made.
据估计,纽约市约20万静脉注射吸毒者(IDU)中有50%感染了艾滋病毒。注射器交换是许多国家常见的艾滋病毒预防方法,1992年在纽约市合法化。随着注射器交换获得公众支持,且该国正常运营的交换点数量不断增加,人们对注射器交换运营特点的研究也越来越多。注射器交换可被视为卫生服务提供机构,其具体的服务提供方式可能会极大地影响它们在减少注射吸毒者艾滋病毒风险行为方面的成效。改善注射器交换的运营特点既需要仔细收集数据以减少解读的模糊性,也需要积累知识的方法,这样就不必在每个新的交换点重复以往的经验。我们在此报告1990年至1994年期间纽约市各交换点分发的注射器标记(“加标签”)做法。在此期间,纽约市的交换点作为地下交换点非法运营,之后获得合法地位并大幅扩张。制定既能反映项目运营实际情况又能便于监督的法规是一个复杂的过程,尤其是在那些维持有关用具和处方法律,且根据现行法律“未经授权”持有注射设备仍属犯罪活动的州实施时。纽约市在项目快速扩张和实施大型注射器交换系统期间需要修订现有法规的特殊情况,进一步说明了这一过程所伴随的多重压力。为了实施有意义的法规,在个人和社区层面最大限度地提高注射器交换项目的公共卫生效益,我们提出了一些建议。